Treat of Functional Ovarian Cysts by Compare Between Cocs and Progesterone Only Pills

Sponsor
Sohag University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05244811
Collaborator
(none)
60
3
10.3

Study Details

Study Description

Brief Summary

comparison between cocs and progesterone only containing pills in treatment of fuctional ovarian cyst

Condition or Disease Intervention/Treatment Phase
Phase 3

Detailed Description

Ovarian cyst is a blister-like sac, which is formed on the surface of ovary during or after ovulation . Most of them are made in reproductive age and are harmless ; these cysts do not cause any symptom and are resolved without treatment , but sometimes they cause health problems that require special attention, and even may lead to infertility. Normal function of ovary is the periodic release of ovums and the production of the steroid hormones of estradiol and progesterone . Both activities are integrated in the continuous repetitive process of follicle maturation, ovulation, and corpus luteum formation and regression. Mature follicle is ruptured and releases ovum during ovulation and corpus luteum is produced from empty follicle if pregnancy does not occur corpus luteum is regressed, due to the absence of hCG (human chorionic gonadotropin). Sometimes this procedure does not happen normally, which results in the formation of ovarian cysts Therefore, functional ovarian cysts are different from ovarian growths induced by other pathological problems most of them regress spontaneously in two or three cycles , but if a cyst gets large, it can twist, be ruptured, or bleed and become very painful .

A functional type of ovarian cyst forms because of slight changes in the way of making or releasing an ovum by the ovary . There are two types of such cysts:

  1. The follicular cyst, which occurs when the sac on ovary does not release an egg and the sac swells up with fluid

  2. The luteal cyst, which is formed when the sac releases an egg and then reseals and fills with fluid

Most functional ovarian cysts are asymptomatic , the larger the cyst, the more likely the symptom. The symptoms are pain or aching in lower abdomen, menstrual irregularity, vaginal bleeding, dyspareunia, etc.; sometimes the cyst is ruptured and causes peritoneal irritation with presentations such as nausea and vomiting or sudden onset of pain, hemorrhagic cyst, intra-abdominal bleeding, and emergency conditions . Some other manifestations such as nausea and vomiting may be felt before the occurrence of such events . Regular pelvic examination is recommended for some patients with the history of such cysts; they also may need regular sonography . Oral contraceptive pills (OCPs) are prescribed by some physician to shrink the cyst, if it is persistent and makes discomfort . Although it seems that they are not effective enough compared with close observation, and even some researchers reported no benefits for OCPs, some others prescribed them before any surgical practices ; therefore, the current study aimed at evaluating this issue. For this purpose, some patients who referred to a private clinic were selected in order to compare the effect of OCPs with close observation in the clinical management of functional ovarian cysts. dyspareunia, or the cysts may be found accidentally on voluntary sonography without any symptoms.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Treatment of Functional Ovarian Cyst Randomised Clinical Trial
Anticipated Study Start Date :
Feb 20, 2022
Anticipated Primary Completion Date :
Jan 1, 2023
Anticipated Study Completion Date :
Jan 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: use of placebo in treatment of functional ovarian cyst

trial the effect of placebo in treatment of functional ovarian cyst

Drug: Combined Oral Contraceptive
effect of cocs in treatment of ovarian cysts
Other Names:
  • cyclo progynova
  • Drug: Progestin
    effect of progestin in treatment of ovarian cystn
    Other Names:
  • primalot-nor
  • Active Comparator: use of cocs in treatment of functional ovarian cyst

    trial of the effectiveness of cocs in the treatment of functional ovarian cyst

    Drug: Combined Oral Contraceptive
    effect of cocs in treatment of ovarian cysts
    Other Names:
  • cyclo progynova
  • Drug: Progestin
    effect of progestin in treatment of ovarian cystn
    Other Names:
  • primalot-nor
  • Active Comparator: use of progesterone in treatment of functional ovarian cyst

    comparison between the effect of progesterone in the treatment of functional ovarian cyst with the effect of cocs

    Drug: Combined Oral Contraceptive
    effect of cocs in treatment of ovarian cysts
    Other Names:
  • cyclo progynova
  • Drug: Progestin
    effect of progestin in treatment of ovarian cystn
    Other Names:
  • primalot-nor
  • Outcome Measures

    Primary Outcome Measures

    1. treatment of functional ovarian cysts [one year]

      rate of treatment of combined oral contraceptive pills in functional ovarian cyst compared with cases who will receive progesterone only pills

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 48 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • The current randomized, clinical trial was performed on females with:-
    1. functional ovarian cysts (4 to 8 cm in diameter)

    2. in reproductive age, within the age range of 18 to 48 years, referred to the Clinic of Gynecological Diseases in a private hospital as outpatient The cysts were identified by transvaginal ultrasonography

    Exclusion Criteria:
    • were history of:-
    1. endometrioma.

    2. Other non-functional .ovarian neoplasm

    3. OCPs consumption during the last three months The patients were randomly divided into three equals

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Sohag University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Abdelhamed Khaled Abdelhameed Farghal, resident doctor in gynaecology and obstetric department in nasser general hospital, Sohag University
    ClinicalTrials.gov Identifier:
    NCT05244811
    Other Study ID Numbers:
    • ovarian cysts
    First Posted:
    Feb 17, 2022
    Last Update Posted:
    Feb 17, 2022
    Last Verified:
    Feb 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    Yes
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    Yes
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 17, 2022